Quantcast

Latest Exocrine pancreatic insufficiency Stories

2014-11-20 12:31:45

HAYWARD, Calif., Nov. 20, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.

2014-07-14 16:24:30

Anthera to Form a New Subsidiary, Alkira Therapeutics, to Assume All Development Activities and Registration Activities as a Subsidiary of Anthera HAYWARD, Calif., July 14, 2014 /PRNewswire/

2011-06-14 08:30:00

ABBOTT PARK, Ill., June 14, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON(R) (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF).

2011-01-12 16:04:00

INDIANAPOLIS, Jan. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced the U.S.

2010-07-02 07:00:00

INDIANAPOLIS and CAMBRIDGE, Mass., July 2 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and Alnara Pharmaceuticals, Inc.

2010-05-03 07:02:00

ABBOTT PARK, Ill.., May 3 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced that the U.S.

2010-04-13 10:13:00

RARITAN, N.J., April 13 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S.


Word of the Day
taphephobia
  • A morbid dread of being buried alive. Also spelled 'taphiphobia'.
The word 'taphephobia' comes from Greek roots meaning 'burial' and 'fear'.
Related